Open access · OA via OpenAlex

Review of Interventions for the Frailty Syndrome and the Role of Metformin as a Potential Pharmacologic Agent for Frailty Prevention

Sara Espinoza, Rozmin Jiwani, Jing Wang, Chen-Pin Wang

Clinical Therapeutics · 2019 · ▲ 30 citations

Stem-cell exhaustion Metformin Review

Abstract

This Clinical Therapeutics 2019 review evaluates existing interventions for frailty syndrome. It discusses the potential role of metformin in prevention.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: OpenAlex
DOI: 10.1016/j.clinthera.2019.01.006
Canonical: link ↗
Fetched: 2026-08-02 MST

Cite this

APA

Espinoza, S., Jiwani, R., Wang, J., & Wang, C. (2019). Review of Interventions for the Frailty Syndrome and the Role of Metformin as a Potential Pharmacologic Agent for Frailty Prevention. <em>Clinical Therapeutics</em>. https://doi.org/10.1016/j.clinthera.2019.01.006

Vancouver

Espinoza S, Jiwani R, Wang J, Wang C. Review of Interventions for the Frailty Syndrome and the Role of Metformin as a Potential Pharmacologic Agent for Frailty Prevention. Clinical Therapeutics. 2019. doi:10.1016/j.clinthera.2019.01.006.

BibTeX

@article{sara2019Review, title = {Review of Interventions for the Frailty Syndrome and the Role of Metformin as a Potential Pharmacologic Agent for Frailty Prevention}, author = {Sara Espinoza and Rozmin Jiwani and Jing Wang and Chen-Pin Wang}, journal = {Clinical Therapeutics}, year = {2019}, doi = {10.1016/j.clinthera.2019.01.006}, }